Gary Charles Robb, Chief Business Officer at CORCEPT THERAPEUTICS INC (CORT), sold 69,872 shares at $19.57 ($1.4M) on 2022-05-19, disclosed to the SEC on 2022-05-19.
Open-market sale of $1.4M CORT by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.55 | 28,745 | $562K | 41.1% |
| 2 | $19.55 | 28,745 | $562K | 41.1% |
| 3 | $19.55 | 128 | $3K | 0.2% |
| 4 | $19.57 | 6,127 | $120K | 8.8% |
| 5 | $19.57 | 6,127 | $120K | 8.8% |
| Total | $19.55 avg | 69,872 |
| $1.4M |
| 100% |
| Filing → |
| CORT | SELL | 2025-06-18 | $451K | — | Filing → |
| CORT | SELL | 2025-05-22 | $346K | — | Filing → |
| CORT | SELL | 2025-01-06 | $556K | — | Filing → |